Skip to content
20-F/A

Annual Report (Foreign)

REGENTIS BIOMATERIALS LTD. RGNT

0001213900-26-021722

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 566.74K sh
Shares Diluted FY 2025 · Dec 31, 2024 2.77M sh
Shares Diluted FY 2025 · Dec 31, 2023 173.51K sh
Shares Outstanding FY 2025 · Dec 31, 2025 5.18M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.38M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$641K
Operating Cash Flow FY 2025 · Dec 31, 2023 −$1.22M
Short Term Debt FY 2025 · Dec 31, 2025 $1.2M
Short Term Debt FY 2025 · Dec 31, 2024 $573K
Short Term Debt FY 2025 · Dec 31, 2023 $210K
Short Term Debt FY 2025 · Aug 31, 2023 $325K
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.38M
Stockholders Equity FY 2025 · Dec 31, 2025 $4.74M
Stockholders Equity FY 2025 · Dec 31, 2024 −$41.1M
Stockholders Equity FY 2025 · Dec 31, 2023 −$45.91M
Stockholders Equity FY 2025 · Dec 31, 2022 −$42.06M
Current Liabilities FY 2025 · Dec 31, 2025 $2.87M
Current Liabilities FY 2025 · Dec 31, 2024 $6.49M
Total Liabilities FY 2025 · Dec 31, 2025 $2.87M
Total Liabilities FY 2025 · Dec 31, 2024 $6.49M
Total Assets FY 2025 · Dec 31, 2025 $7.62M
Total Assets FY 2025 · Dec 31, 2024 $482K
Eps Diluted FY 2025 · Dec 31, 2025 −$24.16
Eps Diluted FY 2025 · Dec 31, 2024 $1.72
Eps Diluted FY 2025 · Dec 31, 2023 −$24.09
Eps Basic FY 2025 · Dec 31, 2025 −$24.16
Eps Basic FY 2025 · Dec 31, 2024 $1.72
Eps Basic FY 2025 · Dec 31, 2023 −$24.09
Sga Expense FY 2025 · Dec 31, 2025 $6.64M
Sga Expense FY 2025 · Dec 31, 2024 $712K
Sga Expense FY 2025 · Dec 31, 2023 $1.13M
Net Income FY 2025 · Dec 31, 2025 −$13.65M
Net Income FY 2025 · Dec 31, 2024 $4.8M
Net Income FY 2025 · Dec 31, 2023 −$4.13M
Operating Income FY 2025 · Dec 31, 2025 −$6.97M
Operating Income FY 2025 · Dec 31, 2024 $932K
Operating Income FY 2025 · Dec 31, 2023 −$1.93M